Cannabidivarin

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameCannabidivarin
Drug Alias NameCBDV - GW Pharmaceuticals次大麻二酚Cannabidivarin - GW PharmaceuticalsGWP-42006
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsAutism Spectrum DisorderSeizuresPrader-Willi Syndrome +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[7
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGw Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsSeizuresPrader-Willi SyndromeEpilepsy

Other Information

ATC CodeN/A
Related LinksWikipedia